WHO ICTRP trial
Discovery of biomarkers in the diagnosis and treatment of benign prostate…
ChiCTR1800020339 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800020339 |
|---|---|
| Public title | Discovery of biomarkers in the diagnosis and treatment of benign prostate hyperplasia |
| Scientific title | Discovery of biomarkers in the diagnosis and treatment of benign prostate hyperplasia |
| Primary sponsor | The affiliated hospital of Xuzhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China |
| Conditions | Benign prostate hyperplasia |
| Interventions | Gold Standard:Histology diagnosis;Index test:Changes in sex hormones and their metabolite levels. |
| Registration date | Dec 25, 2018 |
| Target size | Target condition:200;Difficult condition:200 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: